MarketBeat
08 Aug 2026, 10:04 UTC · 2h ago
Globus Medical Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
08 Aug 2026, 10:04 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Globus Medical raised its full-year adjusted earnings forecast and reported a record non-GAAP diluted EPS of $1.34, a 56% increase year-over-year. — An upward revision in earnings guidance combined with record EPS typically triggers strong positive investor sentiment and price appreciation.
+0.80Adjusted EBITDA margins expanded significantly to 35.4% from 28.0% year-over-year, with the company targeting mid-70% gross margins by 2027. — Strong margin expansion and clear long-term profitability targets indicate improving operational efficiency and pricing power.
+0.60Trauma revenue grew 31% year-over-year and international spine revenue rose 12% on a constant-currency basis. — Strong growth in these diversified segments offsets headwinds in other business units and demonstrates successful market expansion.
+0.50Continue reading
6 related stories
Top 3 movers · tap to explore
Enabling Technologies revenue fell 26% year-over-year due to a strategic shift from cash sales to flexible leasing and rental models. — While management claims this is a long-term play for recurring revenue, a sharp decline in a core segment's revenue creates short-term uncertainty.
-0.30Nevro revenue declined 14.3% year-over-year, with a full recovery in trial volumes not expected until late in the fourth quarter. — Persistent weakness in the acquired pain-management business suggests integration challenges and slow top-line recovery.
-0.20Which stocks this story touches
Reported strong revenue growth, record non-GAAP EPS, expanding margins, and raised its full-year earnings forecast.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
2h ago
